Quality of life considerations and management in patients with myelodysplastic syndrome

Expert Rev Hematol. 2023 Jul-Dec;16(11):849-860. doi: 10.1080/17474086.2023.2268837. Epub 2023 Nov 17.

Abstract

Introduction: This study aimed to identify the factors affecting the quality of life (QOL) and functional status of patients with MDS.

Areas covered: We reviewed the literature published in PUBMED over the past 30 years and searched for keywords such as 'quality of life' and 'myelodysplastic syndromes'. By observing the influence of their symptoms, the possibility of improving patients' QOL was considered by improving these related factors. Concurrently, the effects of related clinical treatments based on the unique disease characteristics of MDS on the patients' QOL were examined, and lifestyle factors were considered in clinical practice, providing an important path to improve the QOL and functional status of patients with MDS.

Expert opinion: This review summarized several areas that can improve the quality of survival of MDS patients and discusses them in depth. Although the clinical benefits may be minimal, we still hope to improve patients' daily life outcomes and enhance their quality of life at minimal cost. Also, we hope more researchers will focus on this area in the future to find more factors that may exist to supplement the limitations of these understanding and thinking, and to provide assistance in clinical work.

Keywords: Myelodysplastic syndrome (MDS); clinical treatment; diet; lifestyle; physical exercise; psychology; quality of life (QOL); sleep.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Myelodysplastic Syndromes* / therapy
  • Quality of Life*